BTAI
BioXcel Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
Implied move unavailable.
Next report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
BioXcel Therapeutics, Inc.
Expected move
Implied move unavailable.
Next report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Implied move unavailable.
Implied move unavailable.
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Millennium ManagementMillennium | $2.5M | 34.39% | +9.19% | |
| 2 | Oaktree Capital ManagementOaktree | $1.6M | 22.43% | +472.27% | |
| 3 | Vanguard Capital ManagementVanguardindex-like | $1.1M | 14.95% | +343.50% | |
| 4 | Oaktree Fund AdvisorsOaktree | $292,000 | 3.99% | +472.29% | |
| 5 | Geode Capital ManagementGeodeindex-like | $288,000 | 3.93% | +5.25% | |
| 6 | BlackRockBlackRockindex-like | $214,000 | 2.92% | +112.90% | |
| 7 | UBS GroupUBS | $188,000 | 2.57% | +199.43% | |
| 8 | Citadel AdvisorsCitadel | $178,000 | 2.43% | new | |
| 9 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $163,000 | 2.23% | +61.25% | |
| 10 | State StreetState Streetindex-like | $110,000 | 1.50% | 0.00% | |
| 11 | FMRFMR | $107,000 | 1.46% | 0.00% | |
| 12 | Wiley Bros.-Aintree CapitalWiley Bros.-Aintree Capital | $99,000 | 1.35% | +3.37% | |
| 13 | Jones Financial Companies LllpJones Financial Companies Lllp | $82,712 | 1.13% | −52.09% | |
| 14 | Northern TrustNorthern Trustindex-like | $67,000 | 0.92% | +55.09% | |
| 15 | HighTower AdvisorsHighTower | $49,000 | 0.67% | 0.00% | |
| 16 | Quadrature CapitalQuadrature Capital | $45,000 | 0.61% | new | |
| 17 | Headlands TechnologiesHeadlands Technologies | $30,000 | 0.41% | new | |
| 18 | Intl FcstoneIntl Fcstone | $25,000 | 0.34% | new | |
| 19 | Beacon Pointe AdvisorsBeacon Pointe | $22,000 | 0.30% | −0.21% | |
| 20 | Susquehanna International GroupSusquehanna International | $20,000 | 0.27% | new | |
| 21 | Portfolio StrategiesPortfolio Strategies | $20,000 | 0.27% | +38.21% | |
| 22 | Virtu FinancialVirtu Financial | $19,000 | 0.26% | new | |
| 23 | Advisor Group HoldingsAdvisor | $19,000 | 0.26% | 0.00% | |
| 24 | Two Sigma SecuritiesTwo Sigma Securities | $13,000 | 0.18% | new | |
| 25 | Wells FargoWells Fargo | $5,000 | 0.07% | +0.42% |
30 managers report $7.3M of BioXcel Therapeutics on form 13F for the quarter ended Jun 30 '26. 6 of them hold 80% of it; Millennium is largest at 34.39%.
BioXcel Therapeutics, Inc.
Price unavailable.